NCT00508222View on ClinicalTrials.gov

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
HIV Infections
Interventions
DRUG

Kaletra Tablets

Kaletra 800/200 OD

Trial Locations (2)

V6Z 2C7

University of British Columbia, Vancouver

K1H 8L6

The Ottawa Hospital, General Campus, Ottawa

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Ottawa Hospital Research Institute

OTHER